Login / Signup

Anti-S100A4 monoclonal antibody treatment ameliorates experimental skin fibrosis and SSc-specific transcriptional signatures in human skin: Comment on the targeting S100A4 is helpful in SSc treatment by Trinh-Minh et al.

An-Fang HuangWang-Dong Xu
Published in: Arthritis & rheumatology (Hoboken, N.J.) (2024)
Keyphrases
  • monoclonal antibody
  • gene expression
  • combination therapy
  • mouse model
  • genome wide
  • replacement therapy